Whereas much of the current attention surrounding GLP-1 RAs, or glucagon-like peptide-1 receptor agonists, has been focused on their unexpected and potent effect on weight loss, one important aspect of this class of drugs should not be overlooked: GLP-1 RAs have been shown to reduce the risk of heart attack, stroke, and other major adverse cardiovascular events (MACE) in patients with type 2 diabetes who have or are at high risk for atherosclerosis
doi:10.1016/S2213-8587(19)30074-4
Semaglutide is most stable in a neutral to slightly basic environment (around pH 78)
L., Pratt, V
CrossRef Pattern analysis for prognosis of differentiated thyroid cancer according to preoperative serum thyrotropin levels Hosu Kim, Jaehoon Jung, Young-Seok Cho, Joon Young Choi, Hyunju Park, You-Bin Lee, Sun Wook Kim, Jae Hoon Chung, Tae Hyuk Kim Scientific Reports.2021;[Epub] CrossRef Restoration for the foregut surgery: bridging gaps between foregut surgery practice and academia Ye-lim Shin, Shin-Hoo Park, Yeongkeun Kwon, Chang Min Lee, Sungsoo Park Journal of Minimally Invasive Surgery.2021